Evaxion A/S

EVAX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001828253

SEC filings (opens in a new tab)

No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Evaxion A/S changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of EVAX: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	9	10	+1
Shares	161.3K	133.7K	−27.6K (−17.1%)
Value	$209.8K	$115.9K	−$93.9K (−44.8%)

New holders (2)

Institutions that held Evaxion A/S at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to EVAX in Q3 2023
Institution	Shares	Value	% of portfolio
AE Wealth Management LLC	48,633	$40.5K	0.00%
Two Sigma Securities, LLC	15,188	$12.7K	0.00%

Sold out (1)

Institutions that held Evaxion A/S at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of EVAX in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Simplex Trading, LLC	1,845	$2.00K